Apelin-13 regulates proliferation, migration and survival of retinal Müller cells under hypoxia

Qiang Lu1, Yan-Rong Jiang, Jing Qian

  • 1Department of Ophthalmology, People's Hospital, Peking University, Beijing, China.

Abstract

Insights

Apelin-13 promotes retinal Müller cell proliferation, migration, and survival while upregulating GFAP and VEGF. Its antagonist, F13A, has opposite effects, indicating apelin-13’s role in Müller cell function.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Molecular Biology

Background:

  • Retinal Müller cells play crucial roles in retinal homeostasis and disease.
  • Apelin-13 is a peptide hormone with diverse physiological functions.
  • The role of apelin-13 in retinal Müller cells remains largely unexplored.

Purpose of the Study:

  • To investigate the in vitro effects of apelin-13 and its receptor antagonist (F13A) on retinal Müller cells.
  • To determine the impact of apelin-13 on Müller cell proliferation, migration, spreading, and apoptosis.
  • To examine the influence of apelin-13 on the expression of glial fibrillary acidic protein (GFAP) and vascular endothelial growth factor (VEGF) in Müller cells.

Main Methods:

  • Immunofluorescence was used to detect apelin-13, GFAP, and VEGF.
  • Cell proliferation, spreading, apoptosis, and migration were assessed using MTT, spreading assays, Annexin/PI staining, and Boyden chamber assays.
  • mRNA and protein levels of apelin-13, GFAP, and VEGF were quantified by real-time PCR and Western blot.

Main Results:

  • Hypoxia increased apelin-13 mRNA and protein levels in Müller cells.
  • Apelin-13 dose-dependently increased GFAP and VEGF protein levels and promoted cell migration and spreading.
  • Apelin-13 reduced Müller cell apoptosis, while F13A exhibited opposing effects.

Conclusions:

  • Apelin-13 significantly modulates Müller cell proliferation, migration, spreading, and survival.
  • Apelin-13 influences the expression of GFAP and VEGF in retinal Müller cells.
  • These findings highlight apelin-13 as a potential therapeutic target in retinal diseases involving Müller cells.